The Department remains focused on growth: in clinical practice and research. You will see our accomplishments in all these areas throughout the update.

It is important to highlight our clinical practice expansion, expanding our presence at our new practice sites throughout the metro area. We have increased representation from all subspecialties at our practices in Westchester, serving adults at the Montefiore Einstein Advanced Care (MEAC) in Elmsford at 555 Taxter Road and children in Harrison at 600 Mamaroneck Avenue. At MEAC we focus on patients with head and neck cancer, thyroid/parathyroid disorders, otologic and neurotologic diseases, rhinology and skull base issues, sleep disorders and facial aesthetic and reconstructive issues. We are also seeing facial aesthetic and reconstructive patients at the newly opened 497 Greenwich practice in Tribeca, which has an on-site surgical center, and at a site in Flushing where we see complex head and neck and skull base patients. In order to facilitate the surgical management of these patients, we have expanded our surgical sites to Montefiore Mount Vernon for adults and Montefiore New Rochelle for children. We have expanded our care team with new physicians, physician assistants and nurse practitioners.  This growth is an important component of improving access to our state-of-the-art care and supporting our relationship with our community partners.

This year we have been, once again, recognized for our simulation expertise, boot camps and in-situ training to improve patient outcomes. As an outcome of these efforts, we have created a new inpatient tracheotomy care team to maximize the care and positive outcomes of our tracheotomy patients and increase staff education to maximize safety.  We continue to successfully participate in clinical trials; with participation in a lymphedema management trial for head and neck cancer patients, intervention trials for head and neck cancer patients, biological therapy for chronic sinusitis patients and others,  and continue to extend our grant portfolio in translational, simulation and quality research.

We look forward to continued expansion of our clinical care and research portfolio in 2025 to further the care of our patients and community.